IMI 2 - The Innovative Medicines Initiative

IMI is a Joint Undertaking (JU) implementing research funding in the area of the further development of medication and is open to all parties within the area of research and development of the EU Member States and Associated States (such as Switzerland). Projects worth funding are financed by the EU and the participating partners from industry.

A project may be submitted by individuals or by consortia. Analogous to the FP7, the refund of the approvable costs amounts up to 75% for universities and research centres, 100% for the management of the approvable costs, and a supplementary 20% refund of the indirect costs